Cepheid (CPHD) – Medical Equipment – Deals and Alliances Profile

Date: 2015-11


Cepheid is a molecular diagnostic company. It offers tests, reagents, and systems for testing in clinical and non-clinical markets. The company’s flagship product, GeneXpert system incorporates sample preparation, nucleic acid extraction and purification, DNA amplification, and detection into a minute, self-contained cartridge. This system facilitates 24/7 rapid molecular testing. Its SmartCycler system integrates DNA amplification and detection for real-time rapid batch or random access analysis. Cepheid also offers GeneXpert system in the areas of GeneXpert system in clinical areas such as healthcare-associated infections, critical infectious disease, sexual health, virology, oncology, women鈥檚 health, and genetics. It also offers GeneXpert modules integrated into the biohazard detection systems (BDS) using its Bacillus anthracis test, and SmartCycler system along with general use PCR reagents and reaction tubes. The company operates along with its subsidiaries in France, Sweden, the US, Japan, Germany, South Africa, the UK, Belgium, Australia, the UAE, China, Italy, Singapore, Brazil, India, and Hong Kong. Cepheid is headquartered in Sunnyvale, California, the US.

The company plans to expand its Xpert product portfolio. To this end, Cepheid collanorated with Rutgers and the Foundation for Innovative New Diagnostics (FIND) to develop Xpert MTB/RIF ultra, a next-generation test for Mycobacterium tuberculosis.

Cepheid (CPHD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.


– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company鈥檚 (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company鈥檚 operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
– Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.”


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample